China Resources Jiangzhong Pharmaceutical Co.,Ltd (SHA:600750)

Market Cap	15.69B +11.1%
Revenue (ttm)	4.07B -6.3%
Net Income	909.82M +13.1%
EPS	1.44 +13.2%
Shares Out	629.46M
PE Ratio	17.32
Forward PE	15.71
Dividend	1.38 (5.54%)
Ex-Dividend Date	n/a

Volume	8,034,052
Average Volume	5,530,579
Open	24.54
Previous Close	24.92
Day's Range	23.93 - 24.98
52-Week Range	21.05 - 27.83
Beta	0.13
RSI	36.97
Earnings Date	Apr 25, 2026

About SHA:600750

China Resources Jiangzhong Pharmaceutical Co.,Ltd engages in the manufacture of pharmaceutical products in China. The company offers OTC products, including stomach-strengthening and digestion-promoting tablets, lactobacillus tablets, triple live bifidobacterium enteric-coated capsules, compound fresh bamboo juice liquid, compound coral lozenges, multivitamin tablets, fritillaria and loquat capsules, bezoar and snake gallbladder fritillaria liquid, and compound gold melon seed. It also provides health consumer and other products, such as nouris...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 4,352
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600750

Financial Performance

In 2025, SHA:600750's revenue was 4.22 billion, a decrease of -4.87% compared to the previous year's 4.44 billion. Earnings were 906.69 million, an increase of 15.03%.